Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
22-Dec-15 iKang Healthcare Group, China's largest private preventive healthcare provider, announced it has acquired 70% interest of Xi'an iKang Health Management, which owns three medical centers under the brand name Xi'an INLUNG. This marks iKang's first steps into Xi'an, capital of Shaanxi Province. [image: Sapphire Healthcare]Read More
21-Dec-15 Australia's doctors lobby has warned the government not to allow health funds to price insurance based on factors such as age and lifestyle, while attacking "junk" policies that don't cover common procedures. Government budgets are under strain and surging costs have put pressure on premiums, prompting a federal review into private insurance and other reviews of the health system. [image: Andrew Meares / The Age]Read More
15-Dec-15 At the recent RSNA exhibition in Chicago, GE proposed a system for information sharing across multiple settings, and Siemens devoted a big chunk of its space to the use of data, while Japanese players used the event to showcase more traditional technology. Finding ways to use data more effectively is assuming growing importance, but Japanese makers appear less interested in following this trend. [image: Nikkei Asian Review]Read More
16-Dec-15 Singapore-based Parkway Pantai, one of Asia's largest healthcare providers, is planning huge healthcare capacities in India, challenging leaders like Apollo and Fortis. Parkway, owned by the Malaysian sovereign fund-backed IHH Healthcare, is planning to add up to 5,000 beds in the next two years, half of this in India, said Dr Tan See Leng, managing director of Parkway and IHH. [image: Business Today]Read More
16-Dec-15 AstraZeneca aims to build up its already strong position in China by making and developing more medicines locally, and will invest more than USD800 mn in the country over the next 10 years. The British drugmaker's decision to step up investment, notably through a strategic alliance with WuXi AppTec, chimes with Beijing's desire to see more treatments made in China. [image: China Daily]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: